References of 4H-Dibenzo[de,g]quinoline-10,11-diol,5,6,6a,7-tetrahydro-6-methyl-, (6aR)-
Title: Apomorphine
CAS Registry Number: 58-00-4
CAS Name: (6a
R)-5,6,6a,7-Tetrahydro-6-methyl-4
H-dibenzo[
de,g]quinoline-10,11-diol
Synonyms: 6ab-aporphine-10,11-diol
Molecular Formula: C17H17NO2
Molecular Weight: 267.32
Percent Composition: C 76.38%, H 6.41%, N 5.24%, O 11.97%
Literature References: Dopamine (D1 and D2) receptor agonist. Synthetic opiate obtained by treating morphine with concd HCl: A. Matthiessen, C. R. A. Wright,
Proc. R. Soc. London Ser. B 17, 455 (1869). Structure: R. Pschorr
et al., Ber. 35, 4377 (1902). Configuration: H. Corrodi, E. Hardegger,
Helv. Chim. Acta 38, 2038 (1955). Total synthesis of (±)-form: J. L. Neumeyer
et al., J. Pharm. Sci. 59, 1850 (1970); of (+)- and (-)-forms: V. J. Ram, J. L. Neumeyer,
J. Org. Chem. 46, 2830 (1981). Toxicity data: J. Z. Ginos
et al., J. Med. Chem. 18, 1194 (1975). Clinical evaluation in impotence: J. P. W. Heaton
et al., Urology 45, 200 (1995). Historical review: J. L. Neumeyer
et al., in
Apomorphine and Other Dopaminomimetics vol. 1, G. L. Gessa, G. U. Corsini, Eds. (Raven, New York, 1981) p 1-17. Comprehensive description: F. J. Muhtadi, M. S. Hifnawy,
Anal. Profiles Drug Subs. 20, 121-166 (1991). Review of pharmacology and clinical efficacy in Parkinson's disease: D. Muguet
et al., Biomed. Pharmacother. 49, 197-209 (1995); in erectile dysfunction: F. Giuliano, J. Allard,
Int. J. Impotence Res. 14, Suppl. 1, S53-S56 (2002).
Properties: Hexagonal plates from chloroform and petr ether, dec 195°; subl in high vacuum. Oxidizes rapidly in air and becomes green. Sol in alcohol, acetone, chloroform. Slightly sol in water, benzene, ether, petr ether. Solns darken rapidly. pKb 7.0; pKa 8.92. uv max (98% alc): 336, 399 nm.
pKa: pKb 7.0; pKa 8.92
Absorption maximum: uv max (98% alc): 336, 399 nm
Derivative Type: Hydrochloride
CAS Registry Number: 314-19-2; 41372-20-7 (hemihydrate)
Trademarks: Apokinon (Aguettant); Apokyn (Mylan Bertek); Apomine (Faulding); Britaject (Britannia); Ixense (Takeda); Uprima (TAP)
Molecular Formula: C17H17NO2.HCl
Molecular Weight: 303.78
Percent Composition: C 67.21%, H 5.97%, N 4.61%, O 10.53%, Cl 11.67%
Properties: Small crystals (usually hemihydrate). Dec and turn green on exposure to light and air. [a]D25 -48° (c = 1.2). uv spectrum: Csokan,
Z. Anal. Chem. 124, 344 (1942). pH of aq soln (1 in 300) = 4.8. One gram dissolves in 50 ml water, 17 ml water at 80°, 50 ml alcohol. Very slightly sol in chloroform and ether. LD50 i.p. in mice: 145 mg/g (Ginos).
Optical Rotation: [a]D25 -48° (c = 1.2)
Toxicity data: LD50 i.p. in mice: 145 mg/g (Ginos)
Derivative Type: Diacetate (ester)
CAS Registry Number: 6191-56-6
Synonyms: Diacetylapomorphine
Molecular Formula: C21H21NO4
Molecular Weight: 351.40
Percent Composition: C 71.78%, H 6.02%, N 3.99%, O 18.21%
Properties: mp 127-128°, [a]D24 -88° (c = 1.12 in 0.1
N HCl).
Melting point: mp 127-128°
Optical Rotation: [a]D24 -88° (c = 1.12 in 0.1
N HCl)
Therap-Cat: Antiparkinsonian; emetic. In treatment of male erectile dysfunction.
Therap-Cat-Vet: Emetic.
Keywords: Antiparkinsonian; Dopamine Receptor Agonist; Emetic; Impotence Therapy.